Bicycletx Limited
Clinical trials sponsored by Bicycletx Limited, explained in plain language.
-
New targeted drug enters trial for Tough-to-Treat lung cancer
Disease control Recruiting nowThis study is testing whether an experimental drug called zelenectide pevedotin can help control advanced lung cancer that has a specific genetic feature (NECTIN4 amplification) and has stopped responding to other treatments. It will involve about 73 people with advanced non-smal…
Phase: PHASE2 • Sponsor: BicycleTx Limited • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug combo targets tough bladder cancers in global trial
Disease control Recruiting nowThis global study is testing a new drug called BT8009, both alone and combined with an existing immunotherapy (pembrolizumab), for people with advanced bladder cancer. It aims to see if these treatments can better control the cancer and extend life. The trial will enroll about 95…
Phase: PHASE2, PHASE3 • Sponsor: BicycleTx Limited • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New targeted drug trial offers hope for tough pancreatic cancer
Disease control Recruiting nowThis study is testing an experimental drug called BT5528 for adults with advanced pancreatic cancer that has spread and worsened after one prior treatment. The drug is designed to find and attack cancer cells by targeting a specific protein they often have. Researchers want to se…
Phase: PHASE2 • Sponsor: BicycleTx Limited • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Targeted attack on advanced breast cancer begins human testing
Disease control Recruiting nowThis study is testing an experimental drug called zelenectide pevedotin for people with advanced breast cancer that has a specific genetic feature called NECTIN4 amplification. It is for patients whose cancer has returned, cannot be surgically removed, or has spread, and who have…
Phase: PHASE2 • Sponsor: BicycleTx Limited • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC